Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2011

Open Access 01-12-2011 | Study protocol

Function, Adjustment, Quality of Life and Symptoms (FAQS) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Survivors: A Study Protocol

Authors: Margaret F Bevans, Sandra A Mitchell, A John Barrett, Michael Bishop, Richard Childs, Daniel Fowler, Michael Krumlauf, Patricia Prince, Nonniekaye Shelburne, Leslie Wehrlen

Published in: Health and Quality of Life Outcomes | Issue 1/2011

Login to get access

Abstract

Background

The population of survivors following allogeneic HSCT continues to increase, and yet their experiences of recovery and long-term survivorship have not been fully characterized. This paper presents a study protocol examining over time the functional status, psychosocial adjustment, health-related quality of life, and symptom experience of survivors who have undergone allogeneic transplantation. The aims of the study are to: 1) explore the patterns of change in these health outcomes during the survivorship phase; 2) characterize subgroups of survivors experiencing adverse outcomes; and 3) examine relationships among outcomes and demographic and clinical factors (such as age, graft-versus-host disease (GVHD), and disease relapse).

Methods

In this longitudinal observational study, adults who survive a minimum of 3 years from date of allogeneic transplantation complete a series of questionnaires annually. Demographic and clinical data are collected along with a series of patient-reported outcome measures, specifically: 1) Medical Outcomes Study SF- 36; 2) Functional Assessment of Chronic Illness Therapy (FACIT) - General, 3) FACIT-Fatigue; 4) FACIT- Spiritual; 5) Psychosocial Adjustment to Illness Scale; 6) Rotterdam Symptom Checklist-Revised; and 7) Pittsburgh Sleep Quality Index.

Conclusions

This study will provide multidimensional patient-reported outcomes data to expand the understanding of the survivorship experience across the trajectory of allogeneic transplantation recovery. There are a number of inherent challenges in recruiting and retaining a diverse and representative sample of long-term transplant survivors. Study results will contribute to an understanding of outcomes experienced by transplant survivors, including those with chronic GVHD, malignant disease relapse, and other late effects following allogeneic transplantation.

Trial Registration

ClinicalTrials.gov: NCT00128960
Literature
1.
Goldman JM, Horowitz MM: The international bone marrow transplant registry. Int J Hematol 2002,76(Suppl 1):393–397. 10.1007/BF03165291PubMedCrossRef
2.
Rodriguez TE, Stiff PJ: Current treatment results of allogeneic bone marrow transplantation for acute myeloid and lymphoid leukemia. Curr Hematol Rep 2003,2(4):295–301.PubMed
3.
Thomas ED, Blume KG: Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 1999,5(6):341–346. 10.1016/S1083-8791(99)70010-8PubMedCrossRef
4.
5.
Appelbaum FR: The current status of hematopoietic cell transplantation. Annu Rev Med 2003, 54: 491–512. 10.1146/annurev.med.54.101601.152456PubMedCrossRef
6.
Horowitz MM: Uses and growth of hematopoietic cell transplantation. In Thomas' hematopoietic cell transplantation. 4th edition. Edited by: Appelbaum F, Thomas ED. Oxford: Wiley-Blackwell; 2009:15–21.CrossRef
7.
Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP: Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999,341(1):14–21. 10.1056/NEJM199907013410103PubMedCrossRef
8.
Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S, Raiola AM, di Grazia C, Dominietto A, Tedone E, Piaggio G, Podesta M, Bruno B, Oneto R, Lombardi A, Frassoni F, Rolla D, Rollandi G, Viscoli C, Ferro C, Garbarino L, Van Lint MT: Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 2004,89(10):1238–1247.PubMed
9.
Serna DS, Lee SJ, Zhang MJ, Baker S, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr: Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol 2003,21(20):3754–3760. 10.1200/JCO.2003.03.133PubMedCrossRef
10.
Pidala J, Anasetti C, Jim H: Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009,114(1):7–19. 10.1182/blood-2008-10-182592PubMedCentralPubMedCrossRef
11.
Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN: Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 2009,18(2):113–127. 10.1002/pon.1399PubMedCentralPubMedCrossRef
12.
Bevans MF, Marden S, Leidy NK, Soeken K, Cusack G, Rivera P, Mayberry H, Bishop MR, Childs R, Barrett AJ: Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006,38(2):101–109. 10.1038/sj.bmt.1705406PubMedCrossRef
13.
Diez-Campelo M, Perez-Simon JA, Gonzalez-Porras JR, Garcia-Cecilia JM, Salinero M, Caballero MD, Canizo MC, Ocio EM, Miguel JF: Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study. Bone Marrow Transplant 2004,34(8):729–738. 10.1038/sj.bmt.1704646PubMedCrossRef
14.
15.
Sun CL, Francisco L, Kawashima T, Leisenring W, Robison LL, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S: Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 2010,116(17):3129–3139. quiz 3377 10.1182/blood-2009-06-229369PubMedCentralPubMedCrossRef
16.
Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JL, Socie G: Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006,12(2):138–151. 10.1016/j.bbmt.2005.09.012PubMedCrossRef
17.
Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Frassoni F, Bacigalupo A: Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000,110(3):614–619. 10.1046/j.1365-2141.2000.02053.xPubMedCrossRef
18.
Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F, Stryckmans P, Peetermans M, Thaler J, Resegotti L, Dardenne M, Willemze R: Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant 1997,20(4):307–315. 10.1038/sj.bmt.1700888PubMedCrossRef
19.
Redaelli A, Stephens JM, Brandt S, Botteman MF, Pashos CL: Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev 2004,30(1):103–117. 10.1016/S0305-7372(03)00142-7PubMedCrossRef
20.
Belec RH: Quality of life: perceptions of long-term survivors of bone marrow transplantation. Oncol Nurs Forum 1992,19(1):31–37.PubMed
21.
Agra Y, Badia X: [Evaluation of psychometric properties of the Spanish version of the Rotterdam Symptom Checklist to assess quality of life of cancer patients]. Rev Esp Salud Publica 1999,73(1):35–44. 10.1590/S1135-57271999000100005PubMedCrossRef
22.
Molassiotis A, van den Akker OB, Milligan DW, Goldman JM, Boughton BJ, Holmes JA, Thomas S: Quality of life in long-term survivors of marrow transplantation: comparison with a matched group receiving maintenance chemotherapy. Bone Marrow Transplant 1996,17(2):249–258.PubMed
23.
Bush NE, Haberman M, Donaldson G, Sullivan KM: Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Soc Sci Med 1995,40(4):479–490. 10.1016/0277-9536(94)00153-KPubMedCrossRef
24.
Hayden PJ, Keogh F, Ni Conghaile M, Carroll M, Crowley M, Fitzsimon N, Gardiner N, Vandenberghe E, O'Riordan J, McCann SR: A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase. Bone Marrow Transplant 2004,34(6):545–556. 10.1038/sj.bmt.1704638PubMedCrossRef
25.
Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH, Messner HA: Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002,20(9):2334–2343. 10.1200/JCO.2002.06.077PubMedCrossRef
26.
Schmidt GM, Niland JC, Forman SJ, Fonbuena PP, Dagis AC, Grant MM, Ferrell BR, Barr TA, Stallbaum BA, Chao NJ, et al.: Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of life. Transplantation 1993,55(3):551–557. 10.1097/00007890-199303000-00018PubMedCrossRef
27.
Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD, Meharchand JM, Atkins H, Tejpar I, Messner HA: Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997,19(11):1129–1136. 10.1038/sj.bmt.1700806PubMedCrossRef
28.
Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME, Martin PJ: Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004,291(19):2335–2343. 10.1001/jama.291.19.2335PubMedCrossRef
29.
Messerer D, Engel J, Hasford J, Schaich M, Ehninger G, Sauerland C, Buchner T, Schumacher A, Krahl R, Niederwieser D, Krauter J, Ganser A, Creutzig U, Dohner H, Schlenk RF: Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 2008,93(6):826–833. 10.3324/haematol.11987PubMedCrossRef
30.
Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ: Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 2005,23(27):6596–6606. 10.1200/JCO.2005.12.674PubMedCrossRef
31.
Andrykowski MA, Altmaier EM, Barnett RL, Burish TG, Gingrich R, Henslee-Downey PJ: Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation. Bone Marrow Transplant 1990,6(4):269–276.PubMed
32.
Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR: Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005,23(3):599–608. 10.1200/JCO.2005.03.189PubMedCrossRef
33.
Andrykowski MA, Henslee PJ, Barnett RL: Longitudinal assessment of psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1989,4(5):505–509.PubMed
34.
Molassiotis A: Quality of life following bone marrow transplant. Nurs Times 1995,91(41):38–39.PubMed
35.
Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM: Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993,11(4):319–327.PubMed
36.
Joseph RW, Couriel DR, Komanduri KV: Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care. J Support Oncol 2008,6(8):361–372.PubMed
37.
Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF, Weiss M, Cohen A, Nekolla E, Kolb HJ: Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997,126(3):184–192.PubMedCrossRef
38.
Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A, Hocker P, Dieckmann K, Fischer G, Rosenmayr A, Linkesch W, Hinterberger W, Lechner K, Greinix HT: Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002,30(9):619–626. 10.1038/sj.bmt.1703677PubMedCrossRef
39.
Socie G, Mary JY, Esperou H, Robert DV, Aractingi S, Ribaud P, Devergie A, Toubert ME, Boudou P, Cathelinau B, Gluckman E, Vexiau P: Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2001,113(1):194–201. 10.1046/j.1365-2141.2001.02678.xPubMedCrossRef
40.
Watson M, Wheatley K, Harrison GA, Zittoun R, Gray RG, Goldstone AH, Burnett AK: Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer 1999,86(7):1231–1239. 10.1002/(SICI)1097-0142(19991001)86:7<1231::AID-CNCR18>3.0.CO;2-YPubMedCrossRef
41.
Mitchell SA, Leidy NK, Mooney KH, Dudley WN, Beck SL, LaStayo PC, Cowen EW, Palit P, Comis LE, Krumlauf MC, Avila DN, Atlam N, Fowler DH, Pavletic SZ: Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant 2010,45(4):762–769. 10.1038/bmt.2009.238PubMedCentralPubMedCrossRef
42.
Beanlands HJ, Lipton JH, McCay EA, Schimmer AD, Elliott ME, Messner HA, Devins GM: Self-concept as a "BMT patient", illness intrusiveness, and engulfment in allogeneic bone marrow transplant recipients. J Psychosom Res 2003,55(5):419–425. 10.1016/S0022-3999(03)00509-9PubMedCrossRef
43.
Heinonen H, Volin L, Zevon MA, Uutela A, Barrick C, Ruutu T: Stress among allogeneic bone marrow transplantation patients. Patient Educ Couns 2005,56(1):62–71. 10.1016/j.pec.2003.12.007PubMedCrossRef
44.
Deeg HJ, Leisenring W, Storb R, Nims J, Flowers ME, Witherspoon RP, Sanders J, Sullivan KM: Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998,91(10):3637–3645.PubMed
45.
Edman L, Larsen J, Hagglund H, Gardulf A: Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation. Eur J Cancer Care (Engl) 2001,10(2):124–130. 10.1046/j.1365-2354.2001.00251.xCrossRef
46.
Lesko LM, Ostroff JS, Mumma GH, Mashberg DE, Holland JC: Long-term psychological adjustment of acute leukemia survivors: impact of bone marrow transplantation versus conventional chemotherapy. Psychosom Med 1992,54(1):30–47.PubMedCrossRef
47.
Watson M, Buck G, Wheatley K, Homewood JR, Goldstone AH, Rees JK, Burnett AK: Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer 2004,40(7):971–978. 10.1016/S0959-8049(03)00628-2PubMedCrossRef
48.
Kopp M, Holzner B, Meraner V, Sperner-Unterweger B, Kemmler G, Nguyen-Van-Tam DP, Nachbaur D: Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Eur J Haematol 2005,74(4):304–308. 10.1111/j.1600-0609.2004.00402.xPubMedCrossRef
49.
Marks DI, Gale DJ, Vedhara K, Bird JM: A quality of life study in 20 adult long-term survivors of unrelated donor bone marrow transplantation. Bone Marrow Transplant 1999,24(2):191–195. 10.1038/sj.bmt.1701867PubMedCrossRef
50.
Wingard JR, Curbow B, Baker F, Zabora J, Piantadosi S: Sexual satisfaction in survivors of bone marrow transplantation. Bone Marrow Transplant 1992,9(3):185–190.PubMed
51.
Bush N, Donaldson G, Moinpour C, Haberman M, Milliken D, Markle V, Lauson J: Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation. Qual Life Res 2005,14(1):77–93. 10.1007/s11136-004-2394-2PubMedCrossRef
52.
Wellisch DK, Centeno J, Guzman J, Belin T, Schiller GJ: Bone marrow transplantation vs. high-dose cytorabine-based consolidation chemotherapy for acute myelogenous leukemia. A long-term follow-up study of quality-of-life measures of survivors. Psychosomatics 1996,37(2):144–154.PubMedCrossRef
53.
Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S: A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant 2004,34(3):257–266. 10.1038/sj.bmt.1704561PubMedCrossRef
54.
So WK, Tai JW: Fatigue and fatigue-relieving strategies used by Hong Kong Chinese patients after hemopoietic stem cell transplantation. Nurs Res 2005,54(1):48–55. 10.1097/00006199-200501000-00007PubMedCrossRef
55.
Gielissen MF, Schattenberg AV, Verhagen CA, Rinkes MJ, Bremmers ME, Bleijenberg G: Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant 2007,39(10):595–603. 10.1038/sj.bmt.1705624PubMedCrossRef
56.
Andrykowski MA, Carpenter JS, Greiner CB, Altmaier EM, Burish TG, Antin JH, Gingrich R, Cordova MJ, Henslee-Downey PJ: Energy level and sleep quality following bone marrow transplantation. Bone Marrow Transplant 1997,20(8):669–679. 10.1038/sj.bmt.1700949PubMedCrossRef
57.
Molassiotis A, Morris PJ: Quality of life in patients with chronic myeloid leukemia after unrelated donor bone marrow transplantation. Cancer Nurs 1999,22(5):340–349. 10.1097/00002820-199910000-00002PubMedCrossRef
58.
Prieto JM, Saez R, Carreras E, Atala J, Sierra J, Rovira M, Batlle M, Blanch J, Escobar R, Vieta E, Gomez E, Rozman C, Cirera E: Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant 1996,17(6):1133–1142.PubMed
59.
Andrykowski MA, Henslee PJ, Farrall MG: Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1989,4(1):75–81.PubMed
60.
Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR: Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol 2007,25(11):1403–1411. 10.1200/JCO.2006.07.5705PubMedCrossRef
61.
Johnson Vickberg SM, Duhamel KN, Smith MY, Manne SL, Winkel G, Papadopoulos EB, Redd WH: Global meaning and psychological adjustment among survivors of bone marrow transplant. Psychooncology 2001,10(1):29–39. 10.1002/1099-1611(200101/02)10:1<29::AID-PON482>3.0.CO;2-YPubMedCrossRef
62.
Molassiotis A: Psychosocial transitions in the long-term survivors of bone marrow transplantation. Eur J Cancer Care (Engl) 1997,6(2):100–107. 10.1046/j.1365-2354.1997.00018.xCrossRef
63.
Molassiotis A, van den Akker OB, Boughton BJ: Perceived social support, family environment and psychosocial recovery in bone marrow transplant long-term survivors. Soc Sci Med 1997,44(3):317–325. 10.1016/S0277-9536(96)00101-3PubMedCrossRef
64.
Wilson IB, Cleary PD: Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995,273(1):59–65. 10.1001/jama.273.1.59PubMedCrossRef
65.
Ashing-Giwa KT: The contextual model of HRQoL: a paradigm for expanding the HRQoL framework. Qual Life Res 2005,14(2):297–307. 10.1007/s11136-004-0729-7PubMedCrossRef
66.
Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992,30(6):473–483. 10.1097/00005650-199206000-00002PubMedCrossRef
67.
Arocho R, McMillan CA: Discriminant and criterion validation of the US-Spanish version of the SF-36 Health Survey in a Cuban-American population with benign prostatic hyperplasia. Med Care 1998,36(5):766–772. 10.1097/00005650-199805000-00017PubMedCrossRef
68.
Arocho R, McMillan CA, Sutton-Wallace P: Construct validation of the USA-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasia. Qual Life Res 1998,7(2):121–126. 10.1023/A:1008801308886PubMedCrossRef
69.
Ayuso-Mateos JL, Lasa L, Vazquez-Barquero JL, Oviedo A, Diez-Manrique JF: Measuring health status in psychiatric community surveys: internal and external validity of the Spanish version of the SF-36. Acta Psychiatr Scand 1999,99(1):26–32. 10.1111/j.1600-0447.1999.tb05381.xPubMedCrossRef
70.
Peek MK, Ray L, Patel K, Stoebner-May D, Ottenbacher KJ: Reliability and validity of the SF-36 among older Mexican Americans. Gerontologist 2004,44(3):418–425.PubMedCrossRef
71.
Dapueto JJ, Francolino C, Servente L, Chang CH, Gotta I, Levin R, Abreu Mdel C: Evaluation of the Functional Assessment of Cancer Therapy-General (FACT-G) Spanish Version 4 in South America: classic psychometric and item response theory analyses. Health Qual Life Outcomes 2003, 1: 32. 10.1186/1477-7525-1-32PubMedCentralPubMedCrossRef
72.
Dapueto JJ, Servente L, Francolino C, Hahn EA: Determinants of quality of life in patients with cancer. Cancer 2005,103(5):1072–1081. 10.1002/cncr.20870PubMedCrossRef
73.
Cella D: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system, Version 4.1. Evanston, IL: Center of Outcomes, Research, and Education (CORE), Evanston Northwestern Healthcare and Northwestern University; 2004.
74.
Cella D, Hernandez L, Bonomi AE, Corona M, Vaquero M, Shiomoto G, Baez L: Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Med Care 1998,36(9):1407–1418. 10.1097/00005650-199809000-00012PubMedCrossRef
75.
Derogatis LR: The psychosocial adjustment to illness scale (PAIS). J Psychosom Res 1986,30(1):77–91. 10.1016/0022-3999(86)90069-3PubMedCrossRef
76.
Derogatis LR, Derogatis MA: PAIS and PAIS-SR: Administration, scoring and procedures manual-II. Baltimore, MD: Clinical Psychometric Research; 1990.
77.
Dirksen SR, Erickson JR: Well-being in Hispanic and non-Hispanic white survivors of breast cancer. Oncol Nurs Forum 2002,29(5):820–826. 10.1188/02.ONF.820-826PubMedCrossRef
78.
de Haes JC, van Knippenberg FC, Neijt JP: Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990,62(6):1034–1038. 10.1038/bjc.1990.434PubMedCentralPubMedCrossRef
79.
De Haes JC, Olschewski M, Fayers PM: Measuring the quality of cancer patients with Rotterdam Symptom Checklist: A manual. Groningen: Northern Center for Health Research; 1996.
80.
Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D: Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med 2002,24(1):49–58. 10.1207/S15324796ABM2401_06PubMedCrossRef
81.
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989,28(2):193–213. 10.1016/0165-1781(89)90047-4PubMedCrossRef
82.
Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A: Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage 2004,27(2):140–148. 10.1016/j.jpainsymman.2003.12.002PubMedCrossRef
83.
Furlani R, Ceolim MF: Sleep quality of women with gynecological and breast cancer. Rev Lat Am Enfermagem 2006,14(6):872–878. 10.1590/S0104-11692006000600007PubMedCrossRef
84.
Wallen GR, Feldman RH, Anliker J: Measuring acculturation among Central American women with the use of a brief language scale. J Immigr Health 2002,4(2):95–102. 10.1023/A:1014550626218PubMedCentralPubMedCrossRef
85.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED: 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995,15(6):825–828.PubMed
86.
Perez-Simon JA, Sanchez-Abarca I, Diez-Campelo M, Caballero D, San Miguel J: Chronic graft-versus-host disease: Pathogenesis and clinical management. Drugs 2006,66(8):1041–1057. 10.2165/00003495-200666080-00002PubMedCrossRef
87.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005,11(12):945–956. 10.1016/j.bbmt.2005.09.004PubMedCrossRef
88.
Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L, McGlave PB, Robison LL, Snyder DS, Weisdorf DJ, Bhatia S: Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004,104(6):1898–1906. 10.1182/blood-2004-03-1010PubMedCrossRef
89.
Baker F, Marcellus D, Zabora J, Polland A, Jodrey D: Psychological distress among adult patients being evaluated for bone marrow transplantation. Psychosomatics 1997,38(1):10–19.PubMedCrossRef
Metadata
Title
Function, Adjustment, Quality of Life and Symptoms (FAQS) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Survivors: A Study Protocol
Authors
Margaret F Bevans
Sandra A Mitchell
A John Barrett
Michael Bishop
Richard Childs
Daniel Fowler
Michael Krumlauf
Patricia Prince
Nonniekaye Shelburne
Leslie Wehrlen
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2011
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-9-24

Other articles of this Issue 1/2011

Health and Quality of Life Outcomes 1/2011 Go to the issue

Research

Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients

Research

Stress-related psycho-physiological disorders: randomized single blind placebo controlled naturalistic study of psychometric evaluation using a radio electric asymmetric treatment

Research

Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in parkinson's disease

Research

Quality of life of patients after retropubic prostatectomy - Pre- and postoperative scores of the EORTC QLQ-C30 and QLQ-PR25

Research

Combined life satisfaction of persons with stroke and their caregivers: associations with caregiver burden and the impact of stroke

Research

The 12-item medical outcomes study short form health survey version 2.0 (SF-12v2): a population-based validation study from Tehran, Iran